SUBSTIPHARM

SUBSTIPHARM is a pharmaceutical company, founded in August 1995 by Mr Cesar BERTHIER - formerly partner and executive president of PHARMAPHARM Laboratory and GENODEX Laboratory. SUBSTIPHARM is the independant company which has the largest investments in registration dossiers in France, with the most important portfolio of products pending registration on the one hand, and development on the other hand. The first objective of SUBSTIPHARM is to successfully register and put on the market generics ; SUBSTIPHARM is used as a partner by pharmaceutical companies, small or large, wanting to operate and develop on this market, but which prefer to buy either a turnkey product or an already registered product, having not the specific organisation required by this type of ( www.substipharm.com )